105-43-1
105-43-1
Chemical Structure
3-Methylvaleric Acid
- CAS No.: 105-43-1
- Formula:C6H12O2
- Molecular Weight:116.16
IUPAC Name: 3-methylpentanoic acid
InChIKey: IGIDLTISMCAULB-UHFFFAOYSA-N
SMILES: CCC(C)CC(O)=O
Biological Activity: 3-Methylvaleric Acid is a branched alkanoic acid. 3-Methylvaleric Acid can be utilized by Pseudomonas citronettotis as a sole carbon source for its growth. 3-Methylvaleric Acid derivatives exhibit anti-hyperalgesic and anticonvulsant activities[1][2][3].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
3-Methylvaleric Acid | 99.99% | 3-Methylvaleric Acid is a branched alkanoic acid. 3-Methylvaleric Acid can be utilized by Pseudomonas citronettotis as a sole carbon source for its growth. 3-Methylvaleric Acid derivatives exhibit anti-hyperalgesic and anticonvulsant activities. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
3-Methylvaleric acid (Standard) | 99.54% | 3-Methylvaleric acid (Standard) is an analytical standard form of 3-Methylvaleric acid (HY-W010513). This product is intended for research and analytical applications. 3-Methylvaleric Acid is a branched alkanoic acid. 3-Methylvaleric Acid can be utilized by Pseudomonas citronettotis as a sole carbon source for its growth. 3-Methylvaleric Acid derivatives exhibit anti-hyperalgesic and anticonvulsant activities. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
3-Methylvaleric acid-d11 | 98.92% | 3-Methylvaleric acid-d11 is the deuterium labeled 3-Methylvaleric Acid (HY-W010513). 3-Methylvaleric Acid is a branched alkanoic acid. 3-Methylvaleric Acid can be utilized by Pseudomonas citronettotis as a sole carbon source for its growth. 3-Methylvaleric Acid derivatives exhibit anti-hyperalgesic and anticonvulsant activities. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Lau E P, et al. Alternate microbial strategies for the metabolism of a 3-methyl branched alkanoic acid. Current Microbiology, 1980, 4: 163-167.
- [2]. Lin YH, et al. Models incorporating physical, laboratory and gut metabolite markers can be used to predict severe hepatic steatosis in MAFLD patients. Kaohsiung J Med Sci. 2024 Dec;40(12):1095-1105. [Content Brief]
- [3]. Kaufmann D, et al. Synthesis and evaluation of antiallodynic and anticonvulsant activity of novel amide and urea derivatives of valproic acid analogues. J Med Chem. 2009 Nov 26;52(22):7236-48. [Content Brief]
